Dot gov

Official websites use the Texas HHS logo.
The Texas HHS logo means this is an official website of Texas Health and Human Services.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

5. References

  1. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc; 2024. Available at: http://www.clinicalpharmacology.com. Accessed June 7, 2024.
  2. Cytomegalovirus immune globulin intravenous – human (Cytogam) package insert. Kamada, LTD. February 2023.
  3. Immune globulin intravenous 5% - human (Flebogamma 5% DIF) package insert. Grifols, November 2019.
  4. Immune globulin intravenous 10% - human (Flebogamma 10% DIF) package insert. Grifols, November 2019.
  5. Immune globulin infusion 10% solution – human (Gammagard Liquid) package insert. Takeda Pharmaceuticals America, Inc. January 2024.
  6. Immune globulin injection 10% - human (Gammaked) package insert.  Kedrion Biopharma, Inc. January 2020.
  7. Immune globulin injection – human (Gamunex-C) package insert. Grifols Therapeutics Inc., April 2022.
  8. Immune globulin intravenous 5% - human (Octagam 5%) package insert.  Octapharma USA Inc., April 2022.
  9. Immune globulin intravenous 10% - human (Octagam 10%) package insert. Octapharma USA Inc., April 2022.
  10. Immune globulin intravenous 10% liquid – human (Privigen) package insert. CSL Behring LLC, April 2022.
  11. Immune globulin subcutaneous- human-hipp (Cutaquig) package insert. Octapharma USA Inc., November 2021.
  12. Immune globulin subcutaneous – human (Cuvitru) package insert. Takeda Pharmaceuticals America, Inc. March 2023.
  13. Immune globulin subcutaneous – human (Hizentra) package insert. CSL Behring LLC. April 2023.
  14. Immune globulin infusion 10% - human, with recombinant human hyaluronidase (Hyqvia) package insert. Takeda Pharmaceuticals America, Inc. January 2024.
  15. Immune globulin subcutaneous- human-klhw (Xembify) package insert. Grifols Therapeutics Inc., February 2022.